• Something wrong with this record ?

The Optimal Maturation of Subcutaneous Pouch Can Improve Pancreatic Islets Engraftment in Rat Model

A. Patikova, A. Vojtiskova, E. Fabryova, L. Kosinova, A. Heribanova, E. Sticova, Z. Berkova, Z. Hladikova, J. Kriz

. 2022 ; 106 (3) : 531-542. [pub] 20220301

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22019340

BACKGROUND: Transplantation of pancreatic islets into subcutaneous cavities in diabetic rats may be as or even more effective than transplantation into the portal vein. Identifying the optimal timing of the individual steps in this procedure is critical. METHODS: Macroporous scaffolds were placed in the subcutaneous tissue of diabetic male Lewis rats for 7 or 28 d and the healing of the tissue inside the scaffolds was monitored. A marginal syngeneic graft comprising 4 islets/g of recipient body weight was transplanted at the best timing focusing mainly on vascularization. Recipients were monitored for blood glucose levels and tolerance tests. Histological examination was performed in all implanted scaffolds. The presence of individual endocrine cells was analyzed in detail. RESULTS: Blood glucose levels remained within the physiological range in all recipients until the end of experiment as well as body weight increase. Coefficients of glucose assimilation were normal or slightly reduced with no statistically significant differences between the groups 40 and 80 d after transplantation. Histological analysis revealed round viable islets in the liver similar to those in pancreas, but alpha cells practically disappeared, whereas islets in the scaffolds formed clusters of cells surrounded by rich vascular network and the alpha cells remained partially preserved. CONCLUSIONS: Subcutaneous transplantation of pancreatic islets is considerably less invasive but comparably efficient as commonly used islet transplantation into the portal vein. In consideration of alpha and beta cell ratio, the artificial subcutaneous cavities represent a promising site for future islet transplantation therapy.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019340
003      
CZ-PrNML
005      
20241210125551.0
007      
ta
008      
220720s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/TP.0000000000003844 $2 doi
035    __
$a (PubMed)34086655
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Patikova, Alzbeta $u Center of Experimental Medicine, Prague, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic
245    14
$a The Optimal Maturation of Subcutaneous Pouch Can Improve Pancreatic Islets Engraftment in Rat Model / $c A. Patikova, A. Vojtiskova, E. Fabryova, L. Kosinova, A. Heribanova, E. Sticova, Z. Berkova, Z. Hladikova, J. Kriz
520    9_
$a BACKGROUND: Transplantation of pancreatic islets into subcutaneous cavities in diabetic rats may be as or even more effective than transplantation into the portal vein. Identifying the optimal timing of the individual steps in this procedure is critical. METHODS: Macroporous scaffolds were placed in the subcutaneous tissue of diabetic male Lewis rats for 7 or 28 d and the healing of the tissue inside the scaffolds was monitored. A marginal syngeneic graft comprising 4 islets/g of recipient body weight was transplanted at the best timing focusing mainly on vascularization. Recipients were monitored for blood glucose levels and tolerance tests. Histological examination was performed in all implanted scaffolds. The presence of individual endocrine cells was analyzed in detail. RESULTS: Blood glucose levels remained within the physiological range in all recipients until the end of experiment as well as body weight increase. Coefficients of glucose assimilation were normal or slightly reduced with no statistically significant differences between the groups 40 and 80 d after transplantation. Histological analysis revealed round viable islets in the liver similar to those in pancreas, but alpha cells practically disappeared, whereas islets in the scaffolds formed clusters of cells surrounded by rich vascular network and the alpha cells remained partially preserved. CONCLUSIONS: Subcutaneous transplantation of pancreatic islets is considerably less invasive but comparably efficient as commonly used islet transplantation into the portal vein. In consideration of alpha and beta cell ratio, the artificial subcutaneous cavities represent a promising site for future islet transplantation therapy.
650    _2
$a zvířata $7 D000818
650    _2
$a krevní glukóza $7 D001786
650    12
$a experimentální diabetes mellitus $x chirurgie $7 D003921
650    12
$a Langerhansovy ostrůvky $x krevní zásobení $x chirurgie $7 D007515
650    12
$a transplantace Langerhansových ostrůvků $x metody $7 D016381
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani inbrední LEW $7 D011917
650    _2
$a subkutánní tkáň $7 D040521
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vojtiskova, Alzbeta $u Center of Experimental Medicine, Prague, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Fabryova, Eva $u Center of Experimental Medicine, Prague, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kosinova, Lucie $u Center of Experimental Medicine, Prague, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Heribanová, Andrea $u First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $7 xx0327061
700    1_
$a Sticova, Eva $u Department of Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Berkova, Zuzana $u Center of Experimental Medicine, Prague, Czech Republic
700    1_
$a Hladikova, Zuzana $u First Faculty of Medicine, Charles University, Prague, Czech Republic $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kriz, Jan $u First Faculty of Medicine, Charles University, Prague, Czech Republic $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
773    0_
$w MED00010695 $t Transplantation $x 1534-6080 $g Roč. 106, č. 3 (2022), s. 531-542
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34086655 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20241210125547 $b ABA008
999    __
$a ok $b bmc $g 1822793 $s 1170583
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 106 $c 3 $d 531-542 $e 20220301 $i 1534-6080 $m Transplantation $n Transplantation $x MED00010695
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Archiving options